Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug design using the example of the complement system inhibitors' development.

Svetlana Bureeva1, Julian Andia-Pravdivy, Alexander Kaplun

  • 1M.V. Lomonosov State Academy of Fine Chemical Technology, Department of Biotechnology, Pr. Vernadskogo 86, 119571 Moscow, Russia. sveta407@mail.ru

Drug Discovery Today
|November 1, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ONT in Clinical Diagnostics of Repeat Expansion Disorders: Detection and Reporting Challenges.

International journal of molecular sciences·2025
Same author

ONT long-read WGS for variant discovery and orthogonal confirmation of short read WGS derived genetic variants in clinical genetic testing.

Frontiers in genetics·2023
Same author

Familial Early-Onset Alzheimer's Caused by Novel Genetic Variant and APP Duplication: A Cross-Sectional Study.

Current Alzheimer research·2022
Same author

Optimization, Characterization and Pharmacokinetic Study of Meso-Tetraphenylporphyrin Metal Complex-Loaded PLGA Nanoparticles.

International journal of molecular sciences·2021
Same author

The Temple Grandin Genome: Comprehensive Analysis in a Scientist with High-Functioning Autism.

Journal of personalized medicine·2021
Same author

A clinically validated whole genome pipeline for structural variant detection and analysis.

BMC genomics·2019

Complement system inhibitors are crucial for treating diseases caused by immune system overactivation. This review details the evolution of drug design methods for creating these vital complement inhibitors.

Area of Science:

  • Immunology
  • Pharmacology
  • Drug Design

Background:

  • The complement system, a key part of innate immunity, can cause significant tissue damage when inappropriately activated.
  • Dysregulation of the complement system is implicated in numerous diseases, including autoimmune disorders, neurodegenerative conditions, and inflammatory diseases.
  • Therapeutic strategies targeting the complement system are essential for managing these pathologies.

Purpose of the Study:

  • To review the historical development and evolution of complement system inhibitors.
  • To illustrate diverse drug design approaches used in developing complement inhibitors.
  • To discuss the current landscape and future directions in complement inhibitor research.

Main Methods:

  • Literature review of complement inhibitor development.

Related Experiment Videos

  • Analysis of drug design strategies, including natural product screening, modification, and structure-based ligand design.
  • Synthesis of information on the historical progression and current status of complement inhibitors.

    • Main Results:

    • The development of complement inhibitors reflects the advancement of drug design methodologies.
    • Key approaches range from early natural product-based methods to sophisticated structure-based ligand design.
    • Significant progress has been made in understanding and targeting the complement cascade for therapeutic benefit.

    Conclusions:

    • Complement inhibitors represent a critical class of therapeutics for a wide range of immune-mediated diseases.
    • The evolution of complement inhibitor design showcases major trends in modern medicinal chemistry and drug discovery.
    • Continued research into complement inhibitors holds promise for novel treatments for debilitating conditions.